This is a preview of subscription content, log in via an institution to check access.
Notes
Canadian dollars
Reference
Goeree R, et al. Cost-Effectiveness Analysis of Secukinumab in Psoriatic Arthritis: a Canadian Perspective. 22nd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research : abstr. PMS26, 20 May 2017. Available from: URL: https://www.ispor.org/ScientificPresentationsDatabase/Presentation/72149?pdfid=49645
Rights and permissions
About this article
Cite this article
Secukinumab cost effective for psoriatic arthritis in Canada. PharmacoEcon Outcomes News 780, 33 (2017). https://doi.org/10.1007/s40274-017-4085-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4085-6